Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development
Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption
Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing
Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer
Precious Metals & Critical Minerals Virtual Investor Conference Presentations Now Available for On-Demand Viewing
CoTec Holdings Corp. Announces Final Closing of Private Placement of Unsecured Convertible Debentures, Total Raise of $20 Million